開云體育app官方網站客戶端114.5M / 音樂播放
開云體育app官方網站app53.6M / iPhone音樂軟件
開云體育app官方網站225.5M / 影音播放
開云體育app官方網站mac版17M / 音樂播放器
開云體育app官方網站iPad版13.6M / iPad音樂軟件
軟件介紹下載地址
開云體育app官方網站作為起步晚、增長快的一款優質音樂播放器,是專注發現與分享的音樂播放器產品,開云體育app官方網站電腦版尤其是創新的音樂社交俘獲了眾多音樂愛好者的心,是用戶口碑、評價甚高的優質音樂應用。
Lee Jae-sun, right, vice president of Samsung Biologics, speaks during the Bio Knowledge Concert event held online, to explain the company's S-DUAL bispecific antibody platform, Thursday. Courtesy of Samsung Biologics |
By Baek Byung-yeul
Samsung Biologics launched S-DUAL, a bispecific antibody platform developed with its own technology, with an aim to improve its capability in the contract-based drug development business, the company said Thursday.
Bispecific antibodies act on two factors simultaneously, not just one factor, which is more effective than a monospecific antibody that acts on only one factor.
Samsung Biologics said its S-DUAL platform is a high-yield bispecific antibody platform with a 99 percent chain-paring success rate. The platform has a unique asymmetrical structure that can reduce risks associated with chemicals.
The company completed a patent application for its own bispecific antibody technology. The self-developed platform can be applied to various next-generation drugs such as multi-specific antibodies.
"We attended the BioProcess International Conference and Exhibition, a bispecific antibody society held in Boston, in September to introduce our S-DUAL platform," Lee Jae-sun, vice president of the company, said during a Bio Knowledge Concert event held online. "The platform was recognized for its innovation by the officials of the academy."
Samsung Biologics said it launched the bispecific antibody platform recognizing its great growth potential. With the platform, Samsung expects that it can improve its competitiveness by providing end-to-end drug development and manufacturing services to its customer companies.
Market tracker EvaluatePharma estimates the bispecific antibody market to grow 32 percent a year to reach $19 billion in 2027 from around $4 billion in 2021. Given the bispecific antibody platform is able to bind two different targets in one form, global biopharmaceutical companies are scrambling to develop bispecific antibody drugs.
To further improve its capability, Samsung Biologics also recently introduced its Developick platform, a service that selects candidate materials for new drugs.
"Samsung Biologics expects to expand its CDMO sales and business portfolio through its own bispecific antibody platform," John Rim, CEO of Samsung Biologics, said in a statement.
72.7M
/簡體94.8M
/簡體44.8M
/簡體45.8M
/簡體85.9M
/簡體307KB
/簡體9.7M
/多國語言[中文]25.1M
/簡體500KB
/簡體237KB
/簡體
- HiFi播放器播放器是音樂發燒友們的必備裝備,自然一款好的播放軟件也是必不可少。播放軟件即高保真無損音樂播放器,可以支持播放各種無損音樂格式,追求極佳音質。對于專業的發燒友來說,無論硬件軟件只要為了好音質,都從不將
24.7M
/簡體16.6M
/簡體44.8M
/簡體72.7M
/簡體13.9M
/多國語言[中文]18.5M
/簡體85.9M
/簡體93.7M
/英文156.4M
/英文1.2M
/簡體
94.8M
/簡體72.7M
/簡體44.8M
/簡體85.9M
/簡體25.1M
/簡體4.7M
/簡體33.6M
/簡體18.5M
/簡體45.8M
/簡體10.1M
/簡體
下載地址
97.1M / 簡體
308.4M / 簡體
117.1M / 簡體
21.0M / 簡體
266.7M / 簡體
10.2M / 簡體
96.5M / 簡體
40.5M / 簡體
32.8M / 簡體
308.4M /
簡體
2G
/簡體6.1M
/簡體68.8M
/簡體225.5M
/簡體120.5M
/簡體53.3M
/簡體103.4M
/簡體56.0M
/簡體136.1M
/簡體69.7M
/簡體
132.0M
/簡體22.9M
/簡體29.1M
/簡體53.6M
/簡體218.2M
/簡體14.1M
/簡體24.7M
/簡體51.2M
/簡體178.0M
/簡體63.0M
/簡體
17M / 簡體
112.4M / 簡體
115.4M
/ 簡體
36.2M / 簡體
985M / 簡體
151M / 簡體
支持( 3 )蓋樓(回復)
支持( 24 )蓋樓(回復)
支持( 936 )蓋樓(回復)
支持( 2754 )蓋樓(回復)
支持( 5322 )蓋樓(回復)
支持( 9 )蓋樓(回復)
支持( 773 )蓋樓(回復)
支持( 58 )蓋樓(回復)
支持( 526 )蓋樓(回復)
支持( 79 )蓋樓(回復)